未登录

M

Mattias K. Andersson

university of gothenburg

H指数:25

被引数:1,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression

泛周期蛋白依赖性激酶抑制是腺样囊性癌的潜在治疗方法，可下调MYB::NFIB融合并诱导肿瘤消退

Cancer Communications

IF24.9

2025-11-120

OAAI

The Transcriptomic and Gene Fusion Landscape of Pleomorphic Salivary Gland Adenomas

GENES CHROMOSOMES & CANCER

IF2.8

2025-01-150

OA

MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature

IF3.9

2024-04-014

OAAI

The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma

IF3

2023-12-274

OA

Comprehensive molecular characterization of adenoid cystic carcinoma reveals tumor suppressors as novel drivers and prognostic biomarkers

JOURNAL OF PATHOLOGY

IF5.2

2023-08-116

OAAI

Increased MYB alternative promoter usage is associated with relapse in acute lymphoblastic leukemia

GENES CHROMOSOMES & CANCER

IF2.8

2023-05-235

OAAI

Synthetic oleanane triterpenoids suppress MYB oncogene activity and sensitize T-cell acute lymphoblastic leukemia cells to chemotherapy

FRONTIERS IN ONCOLOGY

IF3.3

2023-04-034

OAAI

Chromosome Translocations, Gene Fusions, and Their Molecular Consequences in Pleomorphic Salivary Gland Adenomas

IF3.9

2022-08-1416

OAAI

Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner

IF10.1

2021-11-0120

PRE

Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB

GENES CHROMOSOMES & CANCER

IF2.8

2020-08-0516

OAAI

Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells

IF10.1

2020-06-0153

PREAI

ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma

IF6.4

2020-01-3045

OAAI

IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors

IF5.2

2019-08-1637

OAAI

Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2017-05-2276

OAAI

The landscape of gene fusions and somatic mutations in salivary gland neoplasms - Implications for diagnosis and therapy

IF3.9

2016-06-0145

PREAI

Overexpression of MYB drives proliferation of CYLD-defective cylindroma cells

JOURNAL OF PATHOLOGY

IF5.2

2016-04-2127

OAAI

New tricks from an old oncogene Gene fusion and copy number alterations of MYB in human cancer

IF3.4

2014-10-28128

OAAI

Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells

VIRCHOWS ARCHIV

IF3.1

2014-10-2625

PREAI

Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers

IF3.9

2014-08-0189

PREAI

The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitro

BMC MICROBIOLOGY

IF4.2

2013-11-1480

OAAI